Bay Area startup Twist Bioscience is working with Microsoft and University of Washington to find ways to store data on DNA.
Twist has miniaturized the DNA synthesis process, and says it’s able to write DNA faster, at a lower cost, and at a higher throughput than most other synthesis companies. So far, Twist has primarily synthesized genes for companies that bioengineer their drugs using organisms like yeast.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
